We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Pacemaker for Stomach Aids Weight Loss

By HospiMedica staff writers
Posted on 15 Feb 2005
A new gastric stimulator delivers gentle electrical pulses to stimulate the stomach to reduce appetite and hunger.

The implantable gastric stimulator (IGS), called Transcend II, consists of a small battery-operated device that is implanted in the abdomen. More...
Two thin insulated wires connect the device to the stomach wall. Much like a cardiac pacemaker, the gastric stimulator delivers a small current to the stomach, causing it to relax, signaling a feeling of fullness and satiety to the brain, according to the developers. The current can be adjusted through a handheld computer, which "talks” to the pacemaker through a radio signal. Patients usually do not feel anything when the pacemaker is working. The minor surgery can take as little as an hour and patients may not be required to stay overnight.

The Transcend II was developed by Transneuronix, Inc. (Mt. Arlington, NJ, USA) and is now being marketed in Canada by Xycorp Medical, Inc. (Mississauga). Three Centers of Excellence have been selected in Canada to begin using the system. In the United States, the stimulator is limited by the U.S. Food and Drug Administration (FDA) to investigational use.

"It's been remarkably complication-free,” observed Scott Shikora, M.D., of Tufts-New England Medical Center (Boston, MA, USA). Dr. Scott has been testing the device on obese patients for five years.

"It will enable the physician to offer a simple alternative requiring a simple surgical procedure, a short hospital stay, and a low risk of complication,” said Jack Ide, president of Xycorp Medical. "It will revolutionize the treatment of obesity in Canada.”




Related Links:
Xycorp Medical

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.